M-M-R II Lyophilized Powder for Solution for Injection (IM/SC)

Երկիր: Ֆիլիպիններ

Լեզու: անգլերեն

Աղբյուրը: FDA (Food And Drug Administration)

Ակտիվ բաղադրիչ:

Measles, Mumps and Rubella Vaccine (Live, Attenuated)

Հասանելի է:

N/A; Importer: Merck Sharp & Dohme (I.A.) LLC; Distributor: Merck Sharp & Dohme (I.A.) LLC

INN (Միջազգային անվանումը):

Measles, Mumps and Rubella Vaccine (Live, Attenuated)

Դոզան:

REMARKS: Formulation: After reconstitution, each dose (0.5 mL) contains: Live, attenuated virus derived from Edmonston B strain of measles………………… 3.0 log TCID50* Live, attenuated Jeryl Lynn strain of mumps…………..4.1 log TCID50* Live, attenuated Wistar RA27/3 strain of rubella. …………3.0 log TCID50* *TCID 50 - Tissue Culture Infectivity Dose 50%

Դեղագործական ձեւ:

Lyophilized Powder for Solution for Injection (IM/SC)

Միավորները փաթեթում:

Single dose. 3 mL Type I clear glass vial + 0.5 mL clear glass vial (Sterile Water for Injection as diluent) (Box of 1's and 10's)., Single dose. 3 mL Type I clear glass vial + 0.5 mL clear glass vial (Sterile Water for Injection as diluent) (Box of 1's and 10'

Պատրաստված է:

Merck Sharp and Dohme LLC, U.S.A

Ապրանքի ամփոփագիր:

REMARKS: Formulation: After reconstitution, each dose (0.5 mL) contains: Live, attenuated virus derived from Edmonston B strain of measles………………… 3.0 log TCID50* Live, attenuated Jeryl Lynn strain of mumps…………..4.1 log TCID50* Live, attenuated Wistar RA27/3 strain of rubella. …………3.0 log TCID50* *TCID 50 - Tissue Culture Infectivity Dose 50%

Հաստատման ամսաթիվը:

2023-04-26